Clover Health (CLOV) Gains 9% After-Hours as Managed Care Names Rally

Clover Health (CLOV) rose 9% in after-hours trading to $4.82, following a broader rally in managed care stocks. Humana's Q3 2026 earnings report drove sector gains, with Humana up 4.61% during regular trading. Clover's move outpaced peers like CVS Health and Elevance Health.

Original reporting
Published Nov 6, 2026, 9:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 10:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Clover Health (CLOV) Gains 9% After-Hours as Managed Care Names Rally — source image
Decision brief

The 30-second read

$CLOVBullishLow
01

Why it matters

Clover Health outperformed peers in after‑hours, suggesting heightened investor interest relative to larger insurers.

02

Market read

The article highlights a fresh price move for CLOV driven by sector momentum, offering a short‑term trading cue.

03

What to watch

Potential macro‑economic headwinds or upcoming earnings from other health insurers could dampen the sector rally.

Relevance 7/10Novelty 6/10Timing: after‑hours today

Background

Humana reported Q3 earnings that were better than expected, prompting a sector‑wide rally in managed‑care stocks.

Company-level read

Ticker impact

$CLOVBullishMedium confidence
Context

Clover Health shares jumped ~9% in after‑hours trading following Humana's earnings, indicating a fresh sector‑wide catalyst.

Expected impact

potential short‑term upside as market prices in the sector‑wide positive signal

Evidence & confidence

After‑hours moves are often volatile; the catalyst is fresh but thin volume could cause a pull‑back.

Market effects

Managed‑care sector may see modest gains as investors interpret Humana's earnings as a positive outlook for peers.

U.S. healthcare stocks could see slight upward pressure in early trading.

Limited to U.S. healthcare sector; no broader global effect.

Counterpoint

The rally could be a short‑term overreaction; thin after‑hours volume may lead to a pull‑back once regular trading resumes.

Key entities

  • Humana

    Managed‑care insurer whose earnings sparked sector rally.

  • Clover Health

    Health‑tech insurer that saw a 9% after‑hours gain.

Related articles

$CLOVHighAI 8/10

Clover Health (CLOV) Q3 2026 Earnings Call Transcript

Clover Health (CLOV) reported Q3 2026 earnings, highlighting 49% YoY membership growth to 157,000 members, 57% revenue increase to $2.3B, and doubled adjusted EBITDA to $97M. The company achieved high Star Ratings for its plans and improved HEDIS quality performance. Clover Assistant's engagement accelerated, driving better care and economics. The board appointed Clay Thornton as permanent CFO. Management expects continued growth and profitability in 2027 and 2028.

$CLOVMed

What Clover Health Investments (CLOV) Said on Its Q3 Earnings Call

Clover Health (CLOV) reported Q3 2026 revenue of $2.3B (+57% YoY) and net income of $62M (+$98M YoY). Membership grew 49% YoY to 157,000. The company expects continued growth and improved member economics, with higher gross profit per member over time. CLOV has no debt and $513M in cash. Management is optimistic about 2027 membership growth and AI-driven operational improvements.